INFORMATION FOR MEDICAL PROFESSIONALS ONLY

Partner with Us to Enhance Patient Care

Our friendly team is ready to welcome your patients. It is easy to refer your patients to us, simply fill in the form, or call us.

Call Now: 0800 802 1030

Clinical trials and new medications for Alzheimer's

Dr Emer MacSweeney, CEO and Founder of Re:Cognition Health talks about the new medications available for Alzheimer’s disease. We hear the stories of two clinical trial participants, Mike and David, and clinical trial partner, Cheryl, and how participating on a clinical trial for these new medications has helped them.

Leqembi™ Treatment Program for Private Patients

Learn More

Following recent MHRA approval, we are delighted to inform you that the newly approved Alzheimer’s drug will be available for you to refer your patients at Re:Cognition Health’s (RCH’s) centres in London and Bristol.

If private care is not a suitable option for your patients due to cost or the busy treatment schedule, they may like to consider the proactive choice of joining one of our international clinical trials, offering free access to the latest Alzheimer’s treatments.

Our Private Clinic Offerings

We support patients with the following services

ADHD

Assessment, early intervention, and support for ADHD for both children and adults

Learn More
Autism

Assessment, early intervention, and support for Autism for both children and adults

Learn More
New Alzheimer's Medication

New medications for Alzheimer’s available at our private UK clinics.

Learn More
Memory Clinic

Cognitive examination and investigation to identify your memory issues

Learn More
Mental Health

Our psychotherapy, psychiatry, and neuropsychology offerings

Learn More
Neurology Clinics

Disorders of the nervous system such as Alzheimer’s disease, traumatic brain injury, epilepsy, migraines, and cerebral palsy

Learn More
Brain Injury & Concussion

Diagnosing and treating head injuries and long-lasting damage

Learn More

Register your patient for a Clinical Trial

Clinical trials are essential for advancing our understanding of medicine and improving the healthcare and quality of life for everyone affected by dementia and cognitive impairment. To enquire about registering a patient on one of our clinical trials, email us at referrals@re-cognitionhealth.com or call 0800 802 1030

We offer a variety of studies and are looking for participants

According to the Alzheimer’s Society, over 1 million people in the UK will have a diagnosis of dementia by 2025. By 2051 this number will exceed 2 million. Worldwide it’s estimated that 82 million people will be suffering from dementia by 2030.

We are currently looking for volunteers to participate in these studies.

Learn More
We recognise that neurodiversity provides fantastic benefits, as evidenced by the numerous attributes and skills exhibited by individuals living very successful lives with autism.

We are currently looking for volunteers to participate in these studies.

Learn More
Mild Cognitive Impairment affects between 5-20% of people aged 65 years and over in the UK. It is not a form of dementia, however, individuals with MCI often progress to developing dementia.

We are currently looking for volunteers to participate in these studies.

Learn More
At present, there is no cure for Migraine. We’re working on a range of treatment options to change that. Migraines are unbelievably common in the UK, affecting up to 12 million people.

We are currently looking for volunteers to participate in these studies.

Learn More
The currently approved disease-modifying therapies aren’t a cure for MS, but they can reduce how many relapses someone has and how serious they are. They can also slow down the damage caused by relapsing multiple sclerosis that builds up over time. The studies we conduct at Re:Cognition Health are also disease-modifying therapies however aiming to improve the efficacy (the success in slowing progression and/or symptoms) of current medications used.

We are currently looking for volunteers to participate in these studies.

Learn More
Much research is underway in the field of Parkinson’s disease to determine why people develop this condition, as well as new treatments to help treat its symptoms. It is thought that Parkinson’s is caused by a combination of genetic and environmental factors.

We are currently looking for volunteers to participate in these studies.

Learn More

Get our latest news, insights, and expert knowledge

We often host CPD events for GPs and healthcare professionals. Please sign up to be the first to hear of our latest news and upcoming events.

"*" indicates required fields

Educational Videos

Please visit our YouTube channel for more videos.

How to spot the early signs of Alzheimers

Lifestyle Changes to reduce the risk of Alzheimer’s

CTE: The silent killer in contact sports | Emer MacSweeney | TEDxAthens